The first Dexcom trade was made in Q1 2016.
Since then John Paulson bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q1 2017 and Q3 2017.
Avg closing price
Price range
Sold -734 Thousand shares
Q3 2017
Avg closing price
$17.68
Price range
$11.36
-
$18.98
Sold 23.8% shares (-229 Thousand shares)
Q2 2017
Avg closing price
$18.47
Price range
$16.71
-
$20.99
Sold 17.9% shares (-210 Thousand shares)
Q1 2017
Avg closing price
$19.52
Price range
$14.56
-
$21.37
Increased shares by 574.0% (+999 Thousand shares)
Q4 2016
Avg closing price
$17.71
Price range
$14.92
-
$21.24
Sold 64.8% shares (-320 Thousand shares)
Q3 2016
Avg closing price
$22.26
Price range
$19.39
-
$23.95
Increased shares by 199.0% (+329 Thousand shares)
Q2 2016